Interim Phase 3 Analysis: Russian COVID-19 Vaccine Shows 91.6% Efficacy
An interim phase 3 trial shows promising results for the Russian heterologous recombinant adenovirus-based SARS-CoV-2 vaccine.
All articles by Sweta Gupta
Convalescent Plasma With Higher Antibodies Associated With Lower COVID-19 Mortality Risk
Study authors conducted a retrospective study to determine the anti-SARS-CoV-2 IgG antibody levels in convalescent plasma used to treat hospitalized patients with COVID-19.
HIV Diagnosis Linked to Increased COVID-19 Hospitalization, Death in New York State
Study authors investigated the association between HIV diagnosis and COVID-19 diagnosis, hospitalization, and death in New York State.
People Living With HIV May Have Worse COVID-19 Outcomes
The acceleration of the COVID-19 pandemic continues to stress health care systems and exacerbate disparities in many communities, highlighting the importance of identifying patients at elevated risk of severe disease for COVID-19 vaccine prioritization.
Antenatal Influenza Associated With Late Pregnancy Loss and Low Birthweight
Investigators quantified the risk of antenatal influenza and examined its association with perinatal outcomes.
Age-Related Priming Determined Breadth of Influenza A(H3N2) Antibody Landscape in Children
Researchers assessed whether pre-existing antibodies to influenza, which are shaped by early infection and subsequent exposures, impact children’s responses to influenza vaccination.
Determining the Optimal Level of Neutralizing Antibodies Key for COVID-19 Plasma Therapy
Investigators summarized the evidence on the efficacy and adverse effects of antifungal agents in patients with hematological disease or undergoing hematopoietic stem cell transplantation.
Challenges in Assessing the Efficacy of COVID-19 Vaccines
Study authors explored the challenges in assessing the efficacy of COVID-19 vaccines and discussed the caveats needed to interpret efficacy endpoints.
Remdesivir Superior to Placebo in Hospitalized Patients With COVID-19
Researchers assessed if use of intravenous remdesivir in hospitalized patients with coronavirus disease 2019 infection affected time to recovery and clinical status on days 15 and 29.
People With HIV May Have a Higher Susceptibility to COVID-19
Investigators compared the prevalence of HIV among patients hospitalized with COVID-19 compared to the general population and sought to determine whether patients with HIV had higher susceptibility to COVID-19.
-
Loading...
-
Loading...
Next post in Lung Infection
